Aptose Biosciences Inc (APTOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,277 | -28,868 | -11,643 | -14,240 | -11,461 |
| Depreciation Amortization | 613 | 87 | 84 | 116 | 75 |
| Accounts payable and accrued liabilities | 645 | 726 | 589 | -444 | 208 |
| Other Working Capital | 1,888 | 673 | 544 | -126 | 177 |
| Other Operating Activity | 1,573 | 4,175 | 203 | 2,304 | 1,077 |
| Operating Cash Flow | $-21,558 | $-23,207 | $-10,223 | $-12,390 | $-9,924 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -102 | -329 | -13 | -3 | -259 |
| Purchase Of Investment | -17,268 | N/A | N/A | 6,401 | 6,218 |
| Sale Of Investment | N/A | 341 | -798 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 79 | 224 |
| Investing Cash Flow | $-17,370 | $12 | $-811 | $6,477 | $6,183 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 103,885 | 27,886 | 14,025 | 5,726 | 789 |
| Other Financing Activity | -437 | -15 | -307 | 0 | -20 |
| Financing Cash Flow | $103,448 | $27,871 | $13,718 | $5,726 | $770 |
| Exchange Rate Effect | 23 | -8 | 7 | -184 | 728 |
| Beginning Cash Position | 15,299 | 10,631 | 7,940 | 8,311 | 11,256 |
| End Cash Position | 79,842 | 15,299 | 10,631 | 7,940 | 9,014 |
| Net Cash Flow | $64,543 | $4,668 | $2,691 | $-371 | $-2,243 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,558 | -23,207 | -10,223 | -12,390 | -9,924 |
| Capital Expenditure | -102 | -329 | -13 | -3 | -259 |
| Free Cash Flow | -21,660 | -23,536 | -10,236 | -12,393 | -10,182 |